Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

123.97 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
News headline image
2 Fantastic Dividend Stocks to Buy and Hold Forever ↗
These companies have been raising their payouts for a combined 101 consecutive years. 
Via The Motley Fool
Topics Intellectual Property
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗
Via Stocktwits
News headline image
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗
On a big day for tech stocks, some other less well-known companies saw even larger moves. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Why Exact Sciences Rallied Over 50% This Week ↗
The company received a buyout offer from Abbot Labs. 
Via The Motley Fool
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
Via Stocktwits
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Exact Sciences Stock Surged Today ↗
A healthcare giant covets the cancer screening leader's technology. 
Via The Motley Fool
News headline image
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
These S&P500 stocks are gapping in today's session ↗
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
News headline image
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum. 
Via Benzinga
News headline image
Abbott To Acquire Exact Sciences For Up To $23B ↗
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. 
Via Stocktwits
News headline image
Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
A strategic investor is reportedly in advanced talks to purchase the company. 
Via The Motley Fool
News headline image
2 Healthcare Stocks Worth Your Attention and 1 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income ↗
Dividend stocks can strengthen your portfolio during any market environment. 
Via The Motley Fool
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗
These stocks pay income that investors can count on over the long run. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
What Does the Market Think About Abbott Laboratories? ↗
 
Via Benzinga
News headline image
Chicago Fed's 7th District Hiring Expectations Crash to -40: A Dire Signal for the Economy and Fed Policy
The economic outlook for the U.S. Midwest has taken a concerning turn as the Chicago Federal Reserve's 7th District hiring expectations index reportedly plummeted to -40 in October 2025. This alarming... 
Via MarketMinute
Topics Artificial Intelligence Economy Immigration
News headline image
2 Top Dividend Stocks to Buy and Hold Forever ↗
These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party. 
Via The Motley Fool
News headline image
Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility
Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & Supplies - Diversified Stocks
Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Abbott Laboratories (NYSE:ABT) and its peers. 
Via StockStory
News headline image
Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts
The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'... 
Via MarketMinute
Topics Artificial Intelligence Economy Immigration
News headline image
AI's Power Problem ↗
AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast? 
Via The Motley Fool
Topics Artificial Intelligence Economy Energy
News headline image
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat ↗
Via MarketBeat
News headline image
Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook ↗
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled. 
Via Investor's Business Daily
News headline image
Should You Buy DexCom Stock Before Oct. 31? ↗
The company hasn't had a great year. Is it about to turn things around? 
Via The Motley Fool
Topics Lawsuit
News headline image
Recent Corporate Earnings Fuel Market Rally to Record Highs: AI and Rate Cut Hopes Drive Optimism
The third-quarter (Q3) 2025 earnings season has delivered a powerful jolt to global financial markets, propelling major U.S. indices to unprecedented record highs. A wave of surprisingly robust... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Is the Market Bullish or Bearish on Abbott Laboratories? ↗
 
Via Benzinga
News headline image
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? ↗
Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Abbott Laboratories (NYSE:ABT): A Strong Dividend Stock for Reliable Income and Growth ↗
Discover Abbott Laboratories (ABT), a top dividend stock with a 1.87% yield, 11% growth, and a strong financial profile for reliable income. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.